Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181544 · ClinicalTrials.gov registry record · NA
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
A NA study of Renal Failure Chronic Requiring Hemodialysis, sponsored by Vantive Health.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01181544 is a NA study of Renal Failure Chronic Requiring Hemodialysis that has completed, run by Vantive Health. The registered enrollment target is 5 participants, below the 55-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01181544, a NA study of Renal Failure Chronic Requiring Hemodialysis, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.
Conditions Studied
Interventions
- PROCEDURE Heparin dose titration
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01181544
The ClinicalTrials.gov registry entry for NCT01181544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (91% lower). The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Failure Chronic Requiring Hemodialysis appearing as the primary indexed condition, and to 1 intervention - of which Heparin dose titration is the first listed.
NCT01181544 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT01181544 about?
NCT01181544 is a clinical study titled "A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis". During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.
What is the current status of trial NCT01181544?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-03. Estimated completion is 2011-08.
What conditions does trial NCT01181544 study?
This clinical trial studies the following conditions: Renal Failure Chronic Requiring Hemodialysis.
What interventions are being tested in trial NCT01181544?
The interventions under investigation include: Heparin dose titration (PROCEDURE).
Who is sponsoring clinical trial NCT01181544?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01181544 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Failure Chronic Requiring Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.